Analyst Ratings For Exelixis
Portfolio Pulse from Benzinga Insights
Exelixis (NASDAQ:EXEL) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 7% to $30.25. Exelixis has shown strong financial performance with significant revenue growth and high net margins.
October 21, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exelixis has received a mix of bullish and somewhat bullish ratings from analysts, with an increase in the average price target to $30.25. The company's strong financial performance, including a 35.61% revenue growth rate and high net margins, supports a positive outlook.
The majority of analysts have a somewhat bullish outlook on Exelixis, with several raising their price targets. The company's strong financial metrics, such as high revenue growth and net margins, further support a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100